본문 바로가기
KERD
논문KCI 등재

Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: The prevalence of nonalcoholic steatohepatitis (NASH) is increasing with the increasing prevalence of childhood obesity. Although NASH has a high risk of progression to liver fibrosis and cirrhosis, few studies have reported noninvasive markers for predicting hepatic fibrosis in children. This study aimed to evaluate and compare the diagnostic accuracies of serologic biomarkers and scoring systems for hepatic fibrosis in obese children with NASH. Methods: A total of 96 children were diagnosed with NASH based on liver biopsy findings and divided into two groups according to the degree of liver fibrosis: mild (stage 0–1) or advanced (stage 2–4). Clinical and laboratory parameters and serum levels of hyaluronic acid and type IV collagen were measured. The aspartate aminotransferase/platelet ratio index (APRI) and fibrosis-4 (FIB-4) score were calculated. Results: Among the noninvasive markers, only serum type IV collagen level and FIB-4 were significantly different between the two groups. The area under the receiver operating curve of each biomarker and scoring system was 0.80 (95% confidence interval [CI]: 0.70–0.90) for type IV collagen at an optimal cutoff of 148 ng/mL (sensitivity 69.8%, specificity 84.6%), followed by 0.69 (95% CI: 0.57–0.83) for APRI, 0.68 (95% CI: 0.56–0.80) for FIB-4, and 0.65 (95% CI: 0.53-0.77) for hyaluronic acid. Conclusion: Type IV collagen as a single noninvasive serologic biomarker for hepatic fibrosis and FIB-4 as a hepatic fibrosis score are beneficial in predicting advanced hepatic fibrosis and determining proper diagnosis and treatment strategies before fibrosis progresses in obese children with NASH.

Abstract

Purpose: The prevalence of nonalcoholic steatohepatitis (NASH) is increasing with the increasing prevalence of childhood obesity. Although NASH has a high risk of progression to liver fibrosis and cirrhosis, few studies have reported noninvasive markers for predicting hepatic fibrosis in children. This study aimed to evaluate and compare the diagnostic accuracies of serologic biomarkers and scoring systems for hepatic fibrosis in obese children with NASH. Methods: A total of 96 children were diagnosed with NASH based on liver biopsy findings and divided into two groups according to the degree of liver fibrosis: mild (stage 0–1) or advanced (stage 2–4). Clinical and laboratory parameters and serum levels of hyaluronic acid and type IV collagen were measured. The aspartate aminotransferase/platelet ratio index (APRI) and fibrosis-4 (FIB-4) score were calculated. Results: Among the noninvasive markers, only serum type IV collagen level and FIB-4 were significantly different between the two groups. The area under the receiver operating curve of each biomarker and scoring system was 0.80 (95% confidence interval [CI]: 0.70–0.90) for type IV collagen at an optimal cutoff of 148 ng/mL (sensitivity 69.8%, specificity 84.6%), followed by 0.69 (95% CI: 0.57–0.83) for APRI, 0.68 (95% CI: 0.56–0.80) for FIB-4, and 0.65 (95% CI: 0.53-0.77) for hyaluronic acid. Conclusion: Type IV collagen as a single noninvasive serologic biomarker for hepatic fibrosis and FIB-4 as a hepatic fibrosis score are beneficial in predicting advanced hepatic fibrosis and determining proper diagnosis and treatment strategies before fibrosis progresses in obese children with NASH.

참고문헌 (39)

  1. Oh K, "Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005", Korean J Pediatr, 51, pp.950~955 (2008)
  2. Bellentani S, "Epidemiology of non-alcoholic fatty liver disease", Dig Dis, 28, pp.155~161 (2010)
  3. Barshop NJ, "Review article : epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease", Aliment Pharmacol Ther, 28, pp.13~24 (2008)
  4. Vos MB, "NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children : recommendations from the expert committee on NAFLD(ECON)and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition(NASPGHAN)", J Pediatr Gastroenterol Nutr, 64, pp.319~334 (2017)
  5. Powell EE, "The natural history of nonalcoholic steatohepatitis : a follow-up study of forty-two patients for up to 21 years", Hepatology, 11, pp.74~80 (1990)
  6. Molleston JP, "Obese children with steatohepatitis can develop cirrhosis in childhood", Am J Gastroenterol, 97, pp.2460~2462 (2002)
  7. Rockey DC, "Noninvasive measures of liver fibrosis", Hepatology, 43(2 Suppl 1), pp.S113~20 (2006)
  8. Straub BK, "Pathology and biopsy assessment of non-alcoholic fatty liver disease", Dig Dis, 28, pp.197~202 (2010)
  9. Schwimmer JB, "Histopathology of pediatric nonalcoholic fatty liver disease", Hepatology, 42, pp.641~649 (2005)
  10. Guha IN, "Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease", Gut, 55, pp.1650~1660 (2006)
  11. Kim JH, "The 2017 Korean National Growth Charts for children and adolescents : development, improvement, and prospects", Korean J Pediatr, 61, pp.135~149 (2018)
  12. Iacobellis A, "Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis", World J Gastroenterol, 12, pp.7821~7825 (2006)
  13. Loaeza-del-Castillo A, "AST to platelet ratio index(APRI)for the noninvasive evaluation of liver fibrosis", Ann Hepatol, 7, pp.350~357 (2008)
  14. Vallet-Pichard A, "FIB-4 : an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest", Hepatology, 46, pp.32~36 (2007)
  15. Poynard T, "A simple biological index for detection of alcoholic liver disease in drinkers", Gastroenterology, 100(5 Pt 1), pp.1397~1402 (1991)
  16. Kim JM, "Pathologic diagnosis of hepatic fibrosis", Korean J Hepatol, 12(4s), pp.69~74 (2006)
  17. Strauss S, "Interobserver and intraobserver variability in the sonographic assessment of fatty liver", AJR Am J Roentgenol, 189, pp.W320~3 (2007)
  18. Nobili V, "Paediatric non-alcoholic fatty liver disease", Gut, 59, pp.561~564 (2010)
  19. Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
  20. Nobili V, "Blind and ultrasound-guided percutaneous liver biopsy in children", Pediatr Radiol, 33, pp.772~775 (2003)
  21. Gressner AM, "Non-invasive biomarkers for monitoring the fibrogenic process in liver : a short survey", World J Gastroenterol, 15, pp.2433~2440 (2009)
  22. Lesmana CR, "Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis", J Dig Dis, 10, pp.201~206 (2009)
  23. Alkhouri N, "A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis", Clin Gastroenterol Hepatol, 9, pp.150~155 (2011)
  24. Alkhouri N, "Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease", J Hepatol, 57, pp.1312~1318 (2012)
  25. Yang HR, "Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease", World J Gastroenterol, 18, pp.1525~1530 (2012)
  26. Castera L, "Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease", Gastroenterology, 156, pp.1264~1281 (2019)
  27. Enomoto H, "Liver fibrosis markers of nonalcoholic steatohepatitis", World J Gastroenterol, 21, pp.7427~7435 (2015)
  28. Teare JP, "Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis", Lancet, 342, pp.895~898 (1993)
  29. Forns X, "Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model", Hepatology, 36(4 Pt 1), pp.986~992 (2002)
  30. Angulo P, "The NAFLD fibrosis score : a noninvasive system that identifies liver fibrosis in patients with NAFLD", Hepatology, 45, pp.846~854 (2007)
  31. Poynard T, "Biomarkers of liver fibrosis", Adv Clin Chem, 46, pp.131~160 (2008)
  32. Adams LA, "Biomarkers of liver fibrosis", J Gastroenterol Hepatol, 26, pp.802~809 (2011)
  33. Ko JS, "Clinical and histological features of nonalcoholic fatty liver disease in children", Dig Dis Sci, 54, pp.2225~2230 (2009)
  34. Carey E, "Noninvasive tests for liver disease, fibrosis, and cirrhosis : is liver biopsy obsolete?", Cleve Clin J Med, 77, pp.519~527 (2010)
  35. Yoneda M, "Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage", J Gastroenterol, 42, pp.375~381 (2007)
  36. Lydatakis H, "Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease", Liver Int, 26, pp.864~871 (2006)
  37. Oberti F, "Noninvasive diagnosis of hepatic fibrosis or cirrhosis", Gastroenterology, 113, pp.1609~1616 (1997)
  38. Suzuki A, "Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease", Liver Int, 25, pp.779~786 (2005)
  39. Kim E, "The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice", Korean J Pediatr, 56, pp.19~25 (2013)

관련 논문AI추천

A Nomogram for Predicting Non-Alcoholic Fatty Liver Disease in Obese Children문진수, Ahlee Kim, Hye Ran Yang, Jae Sung Ko, Jin Min Cho, Ju Young Chang대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2020 · 제23권 제3호Correlation between Transient Elastography (Fibroscan®) and Ultrasonographic and Computed Tomographic Grading in Pediatric Nonalcoholic SteatohepatitisEun Jung Cheon, Jae Woo Lim, Ji Eun Lee, Jung Min Yoon, Kyung Ok Ko, Young Hwa Song대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2022 · 제25권 제3호The Clinical Significance of Serum Ferritin in Pediatric Non-Alcoholic Fatty Liver Disease고홍, 김승, 강윤구, 나지훈, 박소원대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2014 · 제17권 제4호Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in ChildrenAtike Atalay, Aygen Yılmaz, Cihat Aksoy, Gulsah Kaya Aksoy, Reha Artan, Sebahat Özdem대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2019 · 제22권 제5호Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis김용주, 김자혜, 문진화, 박병한, 윤정민, 이영호, 장세민연세대학교의과대학 · Yonsei Medical Journal2017 · 제58권 제4호Significance of Triglyceride-to-High- Density Lipoprotein Cholesterol Ratio in Children with Non-Alcoholic Fatty Liver DiseaseHyun Jin Kim대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2023 · 제26권 제6호

이 간행물의 다른 논문 (6건)